Nicholas La Thangue
Chief Scientific Officer
Argonaut Therapeutics
United Kingdom
Biography
Nick is a founder of Argonaut Therapeutics and Professor of Cancer Biology at the University of Oxford. He is a Fellow of the Royal Society of Edinburgh, a Member of the European Molecular Biology Organisation (EMBO), a Fellow of the Academy of Medical Sciences, a Fellow of the Lister Institute and Professorial Fellow at Linacre College Oxford. Nick has founded several companies, including Prolifix, Celleron Therapeutics and Oxford Cancer Biomarkers, and has extensive experience derived from the biotechnology and pharmaceutical sectors.
Research Interest
Dr. Nick n having research interest in DNA analysis, Genetics, infectious disease , Molecular Biology, chemistry, of regenerative medicine and tissue engineering, Protein and Peptide Science, Psychology, Vaccine, biotechnology, internal medicine
